Study on the mechanism of Gegen qinlian decoction in improving insulin resistance in mice with impaired glucose tolerance
- VernacularTitle:葛根芩连汤改善糖耐量减低小鼠胰岛素抵抗的作用机制研究
- Author:
Mingzhu SHI
1
;
Bo ZHAO
2
;
Xingguang MI
1
;
Jing CHEN
3
;
Yanhua SI
3
;
Junrui HU
3
;
Min BAI
3
;
Yan SU
4
;
Xiangdong ZHU
5
Author Information
1. School of Traditional Chinese Medicine,Ningxia Medical University,Yinchuan 750001
2. School of Traditional Chinese Medicine,Ningxia Medical University,Yinchuan 750001;School of Clinical Chinese Medicine,Gansu University of Chinese Medicine,Lanzhou 730030
3. School of Traditional Chinese Medicine,Ningxia Medical University,Yinchuan 750001;Key Laboratory of Dryness Syndrome in Chinese Medicine,Ministry of Education,Ningxia Medical University,Yinchuan 750001;Ningxia Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Regional High-prevalence Diseases,Yinchuan 750001
4. Dept. of Endocrine Diabetes,Ningxia Hui Autonomous Region Hospital of Traditional Chinese Medicine and Institute of Traditional Chinese Medicine,Yinchuan 750021
5. School of Traditional Chinese Medicine,Ningxia Medical University,Yinchuan 750001;Key Laboratory of Dryness Syndrome in Chinese Medicine,Ministry of Education,Ningxia Medical University,Yinchuan 750001
- Publication Type:Journal Article
- Keywords:
Gegen qinlian decoction;
impaired glucose tolerance;
Insulin resistance;
gut microbiota;
Antibiotics;
microbiota depletion
- From:
China Pharmacy
2026;37(21):2795-2801
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To investigate the mechanism by which Gegen qinlian decoction (GQD) improves insulin resistance in mice with impaired glucose tolerance (IGT).METHODS An IGT mouse model was induced by high-fat diet. After 4 weeks of intragastric administration of low-, medium- and high-dose GQD (7.5, 15, 30 g/kg, calculated as crude drug), body weight, fasting blood glucose (FBG) and fasting insulin (FINS) levels were measured, and an oral glucose tolerance test (OGTT) was performed. The composition of the gut microbiota was analyzed by 16S rRNA gene sequencing, and the gut microbial metabolite profile was analyzed by untargeted metabolomics; the two datasets were then subjected to integrated analysis. In addition, an antibiotic-induced microbiota depletion experiment was performed to determine whether the effect of GQD on insulin resistance depends on the gut microbiota.RESULTS Compared with normal mice, IGT mice showed significantly increased body weight and insulin resistance-related indices ( P <0.05). After treatment with low-, medium- and high-dose GQD, the above indices were improved to varying degrees in IGT mice, with the high dose producing the greatest improvement ( P <0.05). 16S rRNA gene sequencing showed that, after high-dose GQD treatment, the Chao1 and Shannon indices and the relative abundances of Bacillota and Ileibacterium in the gut microbiota of IGT mice were significantly increased ( P <0.05), whereas the relative abundances of Bacteroidota and Escherichia-Shigella were significantly decreased ( P <0.05). Untargeted metabolomics showed that the samples of the three groups each clustered separately, with clear boundaries between groups. Compared with normal mice, a total of 2 597 differential metabolites were identified in the feces of IGT mice; compared with IGT mice, a total of 2 163 differential metabolites were identified in the feces of mice after high-dose GQD treatment. The differential metabolites were mainly enriched in bile acid metabolism-related pathways. Integrated analysis showed that the changes in the above bacterial genera were consistent with the trends of change in bile acid metabolism-related pathways. After antibiotic-induced microbiota depletion, the effect of GQD in improving insulin resistance in IGT mice was significantly attenuated ( P <0.05).CONCLUSIONS GQD can improve insulin sensitivity and glucose tolerance by correcting dysbiosis and modulating the bile acid biotransformation-related microbiota and their bile acid metabolites.